Division of Infectious Diseases and Immunology Research

At NYU Langone’s Division of Infectious Diseases and Immunology, we believe that research is the engine that drives new medical advances to protect and restore public health locally and globally. Research is an important part of our mission, and our goal is to translate scientific research into innovative ways to prevent, diagnose, and treat infectious diseases.
Our research activities cover the entire span of biomedical discovery—from preclinical laboratory research using animal models, to clinical studies and clinical trials that translate into clinical practice. We also conduct research on healthcare policy, education, and behavior.
We are dedicated to training the next generation of research leaders in the field of infectious diseases and immunology. Important research initiatives within our division include the Vaccine Center, NYU Langone Molecular Outbreak Program, Special Pathogens Program at NYC Health + Hospitals/Bellevue, and hepatitis C elimination studies, as well as research on Staphylococcus aureus bacteria, hepatitis B, influenza, universal flu vaccine, flaviviruses, and yellow fever virus vaccines.
Core Faculty Investigators
Benjamin J. Eckhardt, MD
Assistant Professor, Department of Medicine
Lead Investigator, Hepatitis C Elimination Studies
Ramin Herati, MD
Assistant Professor, Department of Medicine
Mark J. Mulligan, MD
Director, Division of Infectious Diseases and Immunology
Director, Vaccine Center
The Thomas S. Murphy Sr. Professor, Department of Medicine
Vanessa N. Raabe, MD
Assistant Professor, Department of Medicine
Bo Shopsin, MD, PhD
Director, Molecular Epidemiology
Program Director, NYU Langone Molecular Outbreak Program
The Saul J. Farber Assistant Professor of Medicine, Department of Medicine
Assistant Professor, Department of Microbiology
Scott A. Weisenberg, MD
Medical Director, NYU Langone Infectious Disease Associates
Medical Director, Travel Medicine Program
Clinical Associate Professor, Department of Medicine
Faculty Publications
Our faculty publish their research in leading peer-reviewed journals. Learn more about their recent publications.
Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritis
Rheumatology (Oxford). 2022 Dec 23; 62:467-472
COVID-19 Reinfection and Disease Severity in the New York City Health + Hospitals System
Open forum infectious diseases. 2022 Dec 15; 9:
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial
Lancet infectious diseases. 2022 Dec 13;
Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial
Drug & alcohol dependence reports. 2022 Dec; 5:
Molecularly distinct memory CD4+ T cells are induced by SARS-CoV-2 infection and mRNA vaccination
bioRxiv.org : the preprint server for biology. 2022 Nov 16;
Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum
Journal of infectious diseases. 2022 Nov 11; 226:1771-1780
Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia
Nature communications. 2022 Nov 01; 13:5926
Gastroenterology & hepatology. 2022 Nov; 18:628-638